2Fisher B,Brown A,Mamounas E,et al.Effect of preoperative chemotherapy on local-regional diseases in women with operable breast cancer finding from nation surgical adjuvant and bowel project B-18[J].J Clin Oncol,1997,15(7):2483-2493. 被引量：1
3Hutcheon AW,Heys SD,Sarkar TK.Neoadjuvant docetaxel in locally advanced breast cancer[J].Breast Cancer Res Treat,2003,79(1):19-24. 被引量：1
4Elledge RM,Mc Guuie WL.Prognostic factors and therapeutic decisions in axillary node-negative breast cancer[J].Annu RevMed,1993,44:2011. 被引量：1
6Early Breast Cancer Trialistsp Collaborative Group.Polychemotherapy for early breast cancer:An over view of the randomized trials[J].Lancet,1998,352:930. 被引量：1
7Smith RE,Bryant J,DeCillis A,et al.Acute myeloid leukemia and myelodysplastic syndrome after doxorubicin-cyclophosphamide adjuvant therapy for operable breast cancer:the National Surgical Adjuvant Breast and Bowel Project Experience[J].J Clin Oncol,2003,21(7):1195-1204. 被引量：1
8Henderson IC,Berry DA,Demetri GD,et al.Improved outcomes from adding sequential paclitaxel butnot from escalating doxorubicin dose in an adjuvant chemotherapy regmen for patients with node-positive primary breast cancer[J].J Clin Oncol,2003,21(6):976-983. 被引量：1
9Jean MN,Tadeuz P,John M,et al.Phase Ⅲ trial comparing TAC(docetaxel,doxorubicin,cyclophsphamide)with FAC(5-fluorouracil doxorubicin,cyclophsphamide)positive breast cancer (BC) patients:interim analysis of the BCIRG001 study[J].Proc Am Soc Clin Oncol,2002,21:36a. 被引量：1
10Jassem J,Pienknowski T,Pluzanska A,et al.Doxorubicin and paclitaxel versus fluorouracil,doxorubicin,and cyclophosphamide as first-line therapy for women with metastatic breast cancer:final results of a randomized phase Ⅲ multicenter thail[J].J Clin Oncol,2001,19(6):1707-1715. 被引量：1
二级参考文献51
1Otto S J, Fracheboud J, Looman CW, et al. Initiation of population-based mammography screening in Dutch municipalities and effect on breast - cancer mortality : a systematic review [ J ]. Lancet,2003,361 (9367) :1411 - 1417. 被引量：1
2Sam M, Allemani C, Berrino F, et al. Breast cancer survival in Europe and the United States [ J ]. Cancer, 2004,100 ( 8 ) : 715 -722. 被引量：1
3Olsen AH, Njor S, Vejborg W, et al. Breast cancer mortality in Copenhagen after introduction of mammography screening:cohortstudy[ J]. BMJ,2005,330(5 ) :220 - 222. 被引量：1
4Indraneel M, Michael B, Hazel T. Is clinical breast examination an acceptable alternative to mammographic screening? [ J ] BMJ,2000,321 (8) : 1071 - 1073. 被引量：1
5Elmore JG, Armstrong K, Lehman CD, et al. Screening for breast cancer[J]. JAMA,2005,293(10) :1245 - 1256. 被引量：1
6Irwig L,Houssami N,van- Vliet C. New technologies in screening for breast cancer:a systematic review of their accuracy[ J]. Br J Cancer,2004,90( 11 ) :2118 - 2122. 被引量：1
7Plaza CI. Health insurance issue brief: mandated benefits:breast cancer screening coverage requirements : year end report - 2004[ J ]. Issue Brief Health Policy Track Serv,2004,31 ( 1 ) : 1 - 11. 被引量：1
8Smith B. Physician Predictors of Mammographic Accuracy [ J ]. J Natl Cancer Inst,2005,97(5) :358 -367. 被引量：1
9Rawal R, Lorenzo - Bermejo J, Hemminki K. Risk of subsequent invasive breast carcinoma after in situ breast carcinoma in a population covered by national mammographic screening [ J ]. Br J Cancer,2005,92( 1 ) :162 - 166. 被引量：1
10Warner E, Plewes DB, Hill KA, et al. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging,ultrasound, mammography, and clinical breast examination [ J ].JAMA ,2004,292 ( 11 ) : 1317 - 1325. 被引量：1
2Steffi H,Toralf R,Bernd G.Management of Early Invasive Breast Cancer in Very Young Women(<35years)[J].Clini Breast Can-cer,2011,11(4):196-203. 被引量：1
3Krag D,Weaver D,Ashikaga T,et al.The sentinel node in breast cancer:a multicenter validation study[J].N Engl J Med,1998,339(4):941-946. 被引量：1
4Giuliano AE,Dale PS,Turner RR,et al.Improved axillary stag-ing of breast cancer with sentinel lymphadenectomy[J].Ann Surg,1995,222(3):394-401. 被引量：1
5National Comprehensive Cancer Network.NCCN clinical prac-tice guidelines in oncology[J].Breast Cancer,2008[EB/OL]. 被引量：1
6Dowlatshahi K,Alvarado R,Harrison M,et a1.Five yeai follow-up of patients with operable breasl cancer whose sentinol nodes were completely sectioned at0.25mm[J].Cancer Res,2009,69(1):1017. 被引量：1
7Solin LJ,Fourquet A,Mccorrnick B,et al.Salvage treatment for local recurrence following breast-conserving surgery and definitive irrad iationfor ductal carcinoma of the reast[J].Int J Ra-diatned Phys Biol,1994,30(1):3-6. 被引量：1
8Clarke M,Collins R,Darby S,et al.Effects of radiotherapy and of differences in the extent of surgery for early breast can-cer on local recurrence and152year survival:an overview of the randomised trials[J].Lancet,2005,366(9503):2087-2106. 被引量：1
9Vemnesi U,Cascinelli N,Marlani L,et al.Twenty year follow up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer[J].N Engle J Med,2002,347(16):1227-1232. 被引量：1
10Caffo O,Amichetti M,Ferro A,et al.Pain and quality of life after surgery for breast cancer[J].Breast Cancer ResTreat,2003,80(1):39-48. 被引量：1
